No article text was recorded for this version.
efflux pump inhibition
Version 1 of 161 papers89 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Bruton’s Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells
- Blog: Antitumor components and mechanisms of Zanthoxylum bungeanum Maxim with medicine and food homology
- Blog: Remodeling tumor microenvironment with natural products to overcome drug resistance
- Blog: Author Correction: pH-sensitive micelles for the intracellular co-delivery of curcumin and Pluronic L61 unimers for synergistic reversal effect of multidrug resistance
- Blog: Overcoming Tumor Drug Resistance with High‐Affinity Taxanes: A SAR Study of C2‐Modified 7‐Acyl‐10‐Deacetyl Cephalomannines
- Blog: Reversal of Multidrug Resistance by the Chinese Medicine Yiqi Jianpi Huaji Decoction and the Mechanism of Action in Human Gastric Cancer SGC7901/VCR Cells
- Blog: Combinational Antitumor Strategies Based on the Active Ingredients of Toad Skin and Toad Venom
- Blog: Phentolamine Significantly Enhances Macrolide Antibiotic Antibacterial Activity against MDR Gram-Negative Bacteria
- Blog: Advances in Pharmacology and Toxicology of Marine
- Blog: Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells
- Blog: Natural Gastrointestinal Stable Pea Albumin Nanomicelles for Capsaicin Delivery and Their Effects for Enhanced Mucus Permeability at Small Intestine
- Blog: Advances in Therapeutic Implications of Inorganic Drug Delivery Nano-Platforms for Cancer
- Blog: Emodin sensitizes the gemcitabine-resistant cell line Bxpc-3/Gem to gemcitabine via downregulation of NF-κB and its regulated targets
- Blog: Luteolin increases susceptibility to macrolides by inhibiting MsrA efflux pump in Trueperella pyogenes
- Blog: Tailoring traditional Chinese medicine in cancer therapy
- Blog: Development and evaluation of curcumin nano-niosomes for glioma-targeted therapy
- Blog: Electroacupuncture Potentiates Astragaloside IV Cerebral Delivery via P‐Glycoprotein‐Mediated Transcellular Transport: A Novel Blood–Brain Barrier Penetration Strategy for Ischemic Stroke Therapy
- Blog: Natural Melanin-Based Nanoparticles With Combined Chemo/Photothermal/Photodynamic Effect Induce Immunogenic Cell Death (ICD) on Tumor
- Blog: QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats
- Blog: Emerging magic bullet: subcellular organelle-targeted cancer therapy
- Blog: From fighting depression to conquering tumors: a novel tricyclic thiazepine compound as a tubulin polymerization inhibitor
- Blog: Emodin Augments Cisplatin Cytotoxicity in Platinum-Resistant Ovarian Cancer Cells via ROS-Dependent MRP1 Downregulation
- Blog: Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo
- Blog: Inhibition of p38 MAPK increases the sensitivity of 5‑fluorouracil‑resistant SW480 human colon cancer cells to noscapine
- Blog: A Novel Squalenoylated Temozolomide Nanoparticle with Long Circulating Properties Reverses Drug Resistance in Glioblastoma
- Blog: Recent Advances in Calcium‐Based Anticancer Nanomaterials Exploiting Calcium Overload to Trigger Cell Apoptosis
- Blog: Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel
- Blog: RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells.
- Blog: Two inhibitors of yeast plasma membrane ATPase 1 (ScPma1p): toward the development of novel antifungal therapies
- Blog: siRNA-Mediated Silencing of Antifungal Resistance Genes: A Research Protocol
- Blog: A Worldwide Bibliometric Analysis of Tetrandrine Research in Recent Two Decades
- Blog: Ferroptosis: mechanism, immunotherapy and role in ovarian cancer
- Blog: Cantharidin: a double-edged sword in medicine and toxicology
- Blog: Antitumor Activity of Emodin against Pancreatic Cancer Depends on Its Dual Role: Promotion of Apoptosis and Suppression of Angiogenesis
- Blog: A nanoscale natural drug delivery system for targeted drug delivery against ovarian cancer: action mechanism, application enlightenment and future potential
- Blog: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
- Blog: Molecular biology of cantharidin in cancer cells
- Blog: Boron trifluoride etherate promoted microwave-assisted synthesis of antimalarial acridones
- Blog: Synthetic progress and anti-leukemic research on indirubin analogues: a review since 2010
- Blog: A novel, covalent broad-spectrum inhibitor targeting human coronavirus Mpro
- Blog: Engineered nanomedicine targets liver cancer stem cells to treat liver cancer disease
- Blog: HER2-targeting antibody drug conjugate FS-1502 in HER2-expressing metastatic breast cancer: a phase 1a/1b trial
- Blog: Transport Characteristics of Tryptanthrin and its Inhibitory Effect on P-gp and MRP2 in Caco-2 Cells
- Blog: Bacterial evolution of antibiotic hypersensitivity
- Blog: Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer
- Blog: Quantitative Structure–Activity Relationships for the Flavonoid-Mediated Inhibition of P-Glycoprotein in KB/MDR1 Cells
- Blog: Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression
- Blog: Nanoparticle drug delivery systems for synergistic delivery of tumor therapy
- Blog: Apatinib inhibits paclitaxel resistance of gastric carcinoma cells through VEGFR2 pathway.
- Blog: Utidelone inhibits growth of colorectal cancer cells through ROS/JNK signaling pathway
- Blog: Pamiparib Combined with Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer: A Single-Arm, Prospective, Single-Center Clinical Study Protocol
- Blog: Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells
- Blog: The role of a drug-loaded poly (lactic co-glycolic acid) (PLGA) copolymer stent in the treatment of ovarian cancer
- Blog: Stimuli-responsive nanodrug self-assembled from amphiphilic drug-inhibitor conjugate for overcoming multidrug resistance in cancer treatment
- Blog: Liquid Metal Gallium Pharmaceuticals
- Blog: The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
- Blog: Beneficial Diets and Pancreatic Cancer: Molecular Mechanisms and Clinical Practice
- Blog: Quorum sensing inhibitor: an effective strategy to attenuate the virulence and drug resistance of <i>Pseudomonas aeruginosa</i>
- Blog: Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance
- Blog: Evaluation of the effect of GSK-3β on liver cancer based on the PI3K/AKT pathway
Showing 60 of 61 papers.
History & citation
Current · Permanent link
- Overcoming Drug Resistance via Efflux Pump Inhibition merged into this direction (78% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_efflux_pump_inhibition_690a1ab4,
title = {efflux pump inhibition},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/efflux-pump-inhibition/rdr_690a1ab48f6c4aa2b7b1a34092440207},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 1, frozen text):
@misc{lacuna_efflux_pump_inhibition_690a1ab4_v1,
title = {efflux pump inhibition},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/efflux-pump-inhibition/rdr_690a1ab48f6c4aa2b7b1a34092440207/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}